Associations between herpes zoster vaccination and herpes zoster with dementia risk in APOE‐e4 carriers and non‐carriers

AAIC 2025 Abstract

Abstract

Background: Recent studies have reported a reduced risk of dementia in herpes zoster vaccine (HZ‐Vx) recipients. However, none evaluated whether genetic factors influence this potentially protective effect.

The paper

GlaxoSmithKline (United States) · GlaxoSmithKline (United Kingdom)

AAIC 2025 Abstract · 23 Dec 2025 · CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70860_104034